EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis of Folic Acid-Functionalized Hybrid Mesoporous Silica Nanoparticles and In Vitro Evaluation on MCF-7 Breast Cancer Cells

Marta Slavkova iD, Yordan Yordanov iD, Christina Voycheva iD, Teodora Popova iD, Ivanka Spassova iD, Daniela Kovacheva iD, Virginia Tzankova, Borislav Tzankov

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27021092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Marta Slavkova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Folic Acid, Silicon Dioxide, Nanoparticles, Doxorubicin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian National Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Folate receptor alpha is expressed at low levels in normal tissues, but is elevated in aggressive breast cancer types and can be utilized for targeted nanoparticle delivery. Hence, we prepared a hybrid nanocarrier based on in-house synthesized mesoporous silica nanoparticles (MSNs) which were further lipid-coated and reinforced with folic acid (FA). Thorough physicochemical evaluation was performed including dynamic light scattering (DLS), powder x-ray diffraction (PXRD), thermogravimetric analysis (TGA), and nitrogen physisorption. In vitro dissolution of the model drug doxorubicin was carried out in release media with pH 7.4 and pH 5.5. The cytotoxic potential and cellular uptake were investigated in MCF-7 breast cancer cells via the MTT assay, doxorubicin fluorescence measurement, and microscopy. The potential amelioration of doxorubicin’s cardiotoxicity was evaluated in vitro on the H9c2 cell line. The results showed MSNs with significant pore volume (1.38 cm3/g) and relatively small sizes (98.05 ± 1.34 nm). The lipid coat and FA attachment improved the physicochemical stability and sustained release pattern over 24 h. MSNs were non-toxic, while when doxorubicin-loaded, they caused moderate cytotoxicity. The highest cytotoxic activity was observed with folate-functionalized, doxorubicin-loaded nanoparticles (NPs). Even though non-loaded folate-functionalized NPs exhibited significant cytotoxicity, their physical mixture with doxorubicin was inferior in MCF-7 cytotoxicity as opposed to the corresponding loaded nanocarrier. Fluorescence-based quantification showed a higher intracellular accumulation of doxorubicin when delivered via NPs. These results demonstrate the potential to use folate-functionalized NPs as carriers for doxorubicin delivery in breast cancer cells. Its cardiotoxicity was significantly reduced in the case of loading onto the folic acid-functionalized lipid-coated MSNs. All these findings provide a promising proof-of-concept, although further experimental validation, particularly regarding targeting selectivity and safety, is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Folic AcidSilicon DioxideNanoparticlesDoxorubicinBreast NeoplasmsDrug CarriersHumansMCF-7 CellsFemalePorosityCell SurvivalDrug Liberation

Stichwörter der Autor:innen

breast cancercardiotoxicitydoxorubicinfolate targetinghybrid nanoparticleslipid coatingmesoporous silica nanoparticles

Substanzen

Folic AcidSilicon DioxideDoxorubicinDrug Carriers

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
  • Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
  • Institute of General and Inorganic Chemistry, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.

ORCID-Profile: Marta Slavkova, Yordan Yordanov, Christina Voycheva, Teodora Popova, Ivanka Spassova, Daniela Kovacheva

Förderung

  • Bulgarian National Science Fund

Zitieren

APA

Slavkova, M., Yordanov, Y., Voycheva, C., Popova, T., Spassova, I., Kovacheva, D., Tzankova, V., & Tzankov, B. (2026). Synthesis of Folic Acid-Functionalized Hybrid Mesoporous Silica Nanoparticles and In Vitro Evaluation on MCF-7 Breast Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27021092

Vancouver

Slavkova M, Yordanov Y, Voycheva C, Popova T, Spassova I, Kovacheva D, et al. Synthesis of Folic Acid-Functionalized Hybrid Mesoporous Silica Nanoparticles and In Vitro Evaluation on MCF-7 Breast Cancer Cells. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27021092

BibTeX
@article{Slavkova2026,
  author = {Slavkova, Marta and Yordanov, Yordan and Voycheva, Christina and Popova, Teodora and Spassova, Ivanka and Kovacheva, Daniela and Tzankova, Virginia and Tzankov, Borislav},
  title = {Synthesis of Folic Acid-Functionalized Hybrid Mesoporous Silica Nanoparticles and In Vitro Evaluation on MCF-7 Breast Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27021092}
}
Kostenlos starten →